WDR6 and hepatocellular carcinoma: Given that the WDxR motif determined the binding of WDR6 to UVRAG, blocking this binding with one WDxR‐like peptide might improve the effectiveness of anti‐PD‐L1 antibody by reprogramming the TIME in HCC.